Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market - US - 2019-2025 - MedSuite

This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.


EXECUTIVE SUMMARY
U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.2 TYPES OF ARRHYTHMIAS
2.2.11 Atrial Fibrillation
2.2.12 Bradycardia
2.2.13 Conduction Disorders
2.2.13.1 Bundle Branch Block
2.2.13.2 Heart Block
2.2.13.3 Long QT Syndrome (LQTS)
2.2.14 Premature Contractions: PACs and PVCs
2.2.15 Tachycardia
2.2.16 Ventricular Fibrillation
2.2.17 Other Rhythm Disorders
2.2.17.1 Adams-Stokes Disease
2.2.17.2 Atrial Flutter
2.2.17.3 Sick Sinus syndrome
2.2.17.4 Sinus Arrhythmia
2.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
2.2.18 Types of Arrhythmia in Children
2.3 HEART FAILURE
2.4 CARDIAC ARREST
2.5 PATIENT DEMOGRAPHICS
2.5.11 Atrial Fibrillation
2.5.12 Bradycardia
2.5.13 Conduction Disorders
2.5.14 Premature Contractions – PACs and PVCs
2.5.15 Tachycardia
2.5.16 Ventricular Fibrillation
2.5.17 Other Rhythm Disorders  
PRODUCT ASSESSMENT
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Pacemakers
3.2.2 Implantable Cardioverter Defibrillators (ICDs)
3.2.3 Cardiac Resynchronization Therapy (CRT) Devices
3.2.4 Cardiac Leads
3.2.5 External Defibrillators
3.2.6 Lab Systems
3.2.6.1 Introduction
3.2.6.2 3D Mapping Systems
3.2.6.3 EP Recording Systems
3.2.6.4 Remote Steering Systems
3.2.6.5 RF Ablation Generator
3.2.6.6 ICE Systems
3.2.6.7 Product Matrix for Lab Systems: Core Companies
3.2.7 Diagnostic EP Catheters
3.2.7.1 Introduction
3.2.7.2 Diagnostic EP Catheters
3.2.7.3 ICE Catheters
3.2.8 Cardiac Ablation Catheters
3.2.8.1 Introduction
3.2.8.2 RF Ablation Catheters
3.2.8.3 Alternative Energy Catheters
3.2.8.4 High Intensity Focused Ultrasound
3.3 FDA RECALLS
3.3.1 Abbott
3.3.1.1 Pacemakers
3.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.1.4 Cardiac Leads
3.3.1.5 EP Lab Devices
3.3.1.6 Cardiac Ablation Catheter
3.3.2 Biosense Webster
3.3.2.1 EP Lab Devices
3.3.3 Boston Scientific
3.3.3.1 Pacemakers
3.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.3.4 Cardiac Leads
3.3.3.5 EP Lab Devices
3.3.3.6 RF Ablation Catheter
3.3.4 Cardiac Science
3.3.4.1 Automated External Defibrillator (AED)
3.3.5 Medtronic
3.3.5.1 Pacemakers
3.3.5.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.5.4 Cardiac Leads
3.3.5.5 EP Lab Devices
3.3.6 MicroPort
3.3.6.1 Implantable Cardioverter Defibrillators (ICDs)
3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices
3.3.7 Philips Healthcare
3.3.7.1 Automated External Defibrillator (AED)
3.3.8 Stryker Sustainability Solutions
3.3.8.1 Diagnostic EP Catheters
3.3.9 ZOLL
3.3.9.1 Automated External Defibrillator (AED)
3.3.9.2 Wearable Cardioverter Defibrillator (WCD)
3.4 CLINICAL TRIALS
3.4.1 Pacemakers
3.4.2 Implantable Cardioverter Defibrillators (ICDs)
3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
3.4.4 Cardiac Leads
3.4.5 External Defibrillators
3.4.6 Lab Systems
3.4.6.1 3D Mapping Systems
3.4.6.2 EP Recording Systems
3.4.6.3 RF Ablation Generators
3.4.6.4 ICE Systems
3.4.7 Diagnostic EP Catheters
3.4.7.1 Diagnostic Catheter
3.4.8 Cardiac Ablation Catheter
3.4.8.1 RF Ablation Catheters
3.4.8.2 Cryoablation Catheters
3.4.8.3 Laser Ablation Catheters
U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Abbott
4.7.2 Biosense Webster
4.7.3 Biotronik
4.7.4 Boston Scientific
4.7.5 Cardiac Science
4.7.6 GE Healthcare
4.7.7 Medtronic
4.7.8 MicroPort
4.7.9 ZOLL
4.8 SWOT ANALYSIS
4.8.1 Abbott
4.8.2 Biosense Webster
4.8.3 Biotronik
4.8.4 Boston Scientific
4.8.5 Cardiac Science
4.8.6 GE Healthcare
4.8.7 Medtronic
4.8.8 MicroPort
4.8.9 ZOLL
PROCEDURE NUMBERS
5.1 INTRODUCTION
5.2 PROCEDURES
5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures
PACEMAKER MARKET
6.1 INTRODUCTION
6.1.1 Single and Dual-Chamber Devices
6.1.2 MRI-Compatible Pacemaker
6.1.3 Leadless Pacemaker
6.1.4 Initial Placement and Replacement of Pacemakers
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Pacemaker Market
6.3.2 Total Single-Chamber Pacemaker Market
6.3.2.1 Initial Placement Single-Chamber Pacemaker Market
6.3.2.2 Replacement Single-Chamber Pacemaker Market
6.3.3 Total Dual-Chamber Pacemaker Market
6.3.3.1 Initial Placement Dual-Chamber Pacemaker Market
6.3.3.2 Replacement Dual-Chamber Pacemaker Market
6.3.4 Leadless Pacemaker Market
6.4 PRICE ANALYSIS
6.5 DRIVERS AND LIMITERS
6.5.1 Market Drivers
6.5.2 Market Limiters
6.6 COMPETITIVE MARKET SHARE ANALYSIS
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total ICD Market
7.3.2 Total Single-Chamber ICD Market
7.3.2.1 Initial Placement Single-Chamber ICD Market
7.3.2.2 Replacement Single-Chamber ICD Market
7.3.3 Total Dual-Chamber ICD Market
7.3.3.1 Initial Placement Dual-Chamber ICD Market
7.3.3.2 Replacement Dual-Chamber ICD Market
7.3.4 S-ICD Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
8.1 INTRODUCTION
8.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
8.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total CRT Market
8.3.2 Total CRT-P Market
8.3.2.1 Initial Placement CRT-P Market
8.3.2.2 Replacement CRT-P Market
8.3.3 Total CRT-D Market
8.3.3.1 Initial Placement CRT-D Market
8.3.3.2 Replacement CRT-D Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
CARDIAC LEADS MARKET
9.1 INTRODUCTION
9.1.1 Replacement of Leads
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Total Cardiac Lead Market
9.3.2 Pacing Lead Market
9.3.3 Defibrillation Lead Market
9.3.4 LV Lead Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
ELECTROCARDIOGRAPHY MONITORING MARKET
10.1 INTRODUCTION
10.1.1 Holter Monitoring
10.1.2 Stress Testing
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Resting ECG Device Market
10.3.1.1 Hospital-Based Resting ECG Device Market
10.3.1.2 Total Office-Based Resting ECG Device Market
10.3.1.2.1 Purpose-Built Office-Based Resting ECG Device Market
10.3.1.2.2 PC-Based Office-Based Resting ECG Device Market
10.3.2 Total Stress Testing Device Market
10.3.2.1 Hospital-Based Stress Testing Device Market
10.3.2.2 Office-Based Stress Testing Device Market
10.3.3 Total Holter Monitoring Recorder Market
10.3.3.1 Hospital-Based Holter Monitoring Recorder Market
10.3.3.2 Office-Based Holter Monitoring Recorder Market
10.3.3.3 IDTF Holter Monitoring Recorder Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
LAB SYSTEMS MARKET
11.1 INTRODUCTION
11.1.1 3D Mapping Systems
11.1.2 EP Recording Systems
11.1.3 Remote Steering Systems
11.1.4 RF Ablation Generator
11.1.5 ICE System
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 3D Mapping Market
11.3.2 EP Recording Market
11.3.3 RF Ablation Generator Market
11.3.4 Remote Steering System Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET
12.1 INTRODUCTION
12.1.1 Diagnostic Electrophysiology Catheters
12.1.2 Reprocessed Catheters
12.1.3 Intracardiac Echocardiography
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Total Diagnostic Electrophysiology Catheters Market
12.3.2 Total EP Conventional Catheter Market
12.3.2.1 Fixed EP Catheter Market
12.3.2.2 Steerable EP Catheter Market
12.3.3 EP Advanced Catheter Market
12.3.4 ICE Diagnostic Catheter Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
CARDIAC ABLATION CATHETER MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Cardiac Ablation Catheter Market
13.3.2 RF Ablation Catheter Market
13.3.2.1 Irrigated RF Ablation Catheter Market
13.3.2.2 Non-Irrigated RF Ablation Catheter Market
13.3.3 Cryoablation Catheter Market
13.4 DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE MARKET SHARE ANALYSIS
APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET
14.1 INTRODUCTION
14.2 MARKET ANALYSIS AND FORECAST
14.3 DRIVERS AND LIMITERS
14.3.1 Market Drivers
14.3.2 Market Limiters
14.4 COMPETITIVE MARKET SHARE ANALYSIS
APPENDIX II: CRYOABLATION GENERATOR MARKET
15.1 INTRODUCTION
15.2 MARKET ANALYSIS AND FORECAST
15.3 DRIVERS AND LIMITERS
15.3.1 Market Drivers
15.3.2 Market Limiters
15.4 COMPETITIVE MARKET SHARE ANALYSIS
APPENDIX III: EXTERNAL DEFIBRILLATOR MARKET
16.1 INTRODUCTION
16.1.1 Automated External Defibrillator
16.1.2 Wearable Cardioverter Defibrillator
16.2 MARKET OVERVIEW
16.3 MARKET ANALYSIS AND FORECAST
16.3.1 Total External Defibrillator Market
16.3.2 Automated External Defibrillator Market
16.3.3 Wearable Cardioverter Defibrillator Market
16.4 DRIVERS AND LIMITERS
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
LIST OF CHARTS
Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025
Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, U.S., 2018 & 2025
Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025
Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2018
Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2025
Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2016 – 2025
Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018
Chart 5 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025
Chart 6 1: Pacemaker Market by Segment, U.S., 2015 – 2025
Chart 6 2: Pacemaker Market Breakdown, U.S., 2018
Chart 6 3: Pacemaker Market Breakdown, U.S., 2025
Chart 6 4: Total Pacemaker Market, U.S., 2015 – 2025
Chart 6 5: Single-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025
Chart 6 6: Total Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 7: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 8: Replacement Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 9: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025
Chart 6 10: Total Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 11: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 12: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Chart 6 13: Leadless Pacemaker Market, U.S., 2015 – 2025
Chart 6 14: Leading Competitors, Pacemaker Market, U.S., 2018
Chart 7 1: ICD Market by Segment, U.S., 2015 – 2025
Chart 7 2: ICD Market Breakdown, U.S., 2018
Chart 7 3: ICD Market Breakdown, U.S., 2025
Chart 7 4: Total ICD Market, U.S., 2015 – 2025
Chart 7 5: Single-Chamber ICD Market by Segment, U.S., 2015 – 2025
Chart 7 6: Total Single-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 7: Initial Placement Single-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 8: Replacement Single-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 9: Dual-Chamber ICD Market by Segment, U.S., 2015 – 2025
Chart 7 10: Total Dual-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 11: Initial Placement Dual-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 12: Replacement Dual-Chamber ICD Market, U.S., 2015 – 2025
Chart 7 13: S-ICD Market, U.S., 2015 – 2025
Chart 7 14: Leading Competitors, ICD Market, U.S., 2018
Chart 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 – 2025
Chart 8 2: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2018
Chart 8 3: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2025
Chart 8 4: Total CRT Market, U.S., 2015 – 2025
Chart 8 5: CRT-P Market by Segment, U.S., 2015 – 2025
Chart 8 6: Total CRT-P Market, U.S., 2015 – 2025
Chart 8 7: Initial Placement CRT-P Market, U.S., 2015 – 2025
Chart 8 8: Replacement CRT-P Market, U.S., 2015 – 2025
Chart 8 9: CRT-D Market by Segment, U.S., 2015 – 2025
Chart 8 10: Total CRT-D Market, U.S., 2015 – 2025
Chart 8 11: Initial Placement CRT-D Market, U.S., 2015 – 2025
Chart 8 12: Replacement CRT-D Market, U.S., 2015 – 2025
Chart 8 13: Leading Competitors, CRT Market, U.S., 2018
Chart 9 1: Cardiac Lead Market by Segment, U.S., 2015 – 2025
Chart 9 2: Cardiac Lead Market Breakdown, U.S., 2018
Chart 9 3: Cardiac Lead Market Breakdown, U.S., 2025
Chart 9 4: Total Cardiac Lead Market, U.S., 2015 – 2025
Chart 9 5: Pacing Lead Market, U.S., 2015 – 2025
Chart 9 6: Defibrillation Lead Market, U.S., 2015 – 2025
Chart 9 7: LV Lead Market, U.S., 2015 – 2025
Chart 9 8: Leading Competitors, Cardiac Lead Market, U.S., 2018
Chart 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 – 2025
Chart 10 2: Electrocardiography Monitoring Market Breakdown, U.S., 2018
Chart 10 3: Electrocardiography Monitoring Market Breakdown, U.S., 2025
Chart 10 4: Resting ECG Device Market by Segment, U.S., 2015 – 2025
Chart 10 5: Total Resting ECG Device Market, U.S., 2015 – 2025
Chart 10 6: Hospital-Based Resting ECG Device Market, U.S., 2015 – 2025
Chart 10 7: Office-Based Resting ECG Device Market by Segment, U.S., 2015 – 2025
Chart 10 8: Total Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Chart 10 9: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Chart 10 10: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Chart 10 11: Stress Testing Device Market by Segment, U.S., 2015 – 2025
Chart 10 12: Total Stress Testing Device Market, U.S., 2015 – 2025
Chart 10 13: Hospital-Based Stress Testing Device Market, U.S., 2015 – 2025
Chart 10 14: Office-Based Stress Testing Device Market, U.S., 2015 – 2025
Chart 10 15: Holter Monitoring Recorder Market by Segment, U.S., 2015 – 2025
Chart 10 16: Total Holter Monitoring Recorder Market, U.S., 2015 – 2025
Chart 10 17: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025
Chart 10 18: Office-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025
Chart 10 19: IDTF Holter Monitoring Recorder Market, U.S., 2015 – 2025
Chart 10 20: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018
Chart 11 1: Lab Systems Market by Segment, U.S., 2015 – 2025
Chart 11 2: Lab Systems Market Breakdown, U.S., 2018
Chart 11 3: Lab Systems Market Breakdown, U.S., 2025
Chart 11 4: 3D Mapping Market, U.S., 2015 – 2025
Chart 11 5: EP Recording Market, U.S., 2015 – 2025
Chart 11 6: RF Ablation Generator Market, U.S., 2015 – 2025
Chart 11 7: Remote Steering System Market, U.S., 2015 – 2025
Chart 11 8: Leading Competitors, Lab Systems Market, U.S., 2018
Chart 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 – 2025
Chart 12 2: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2018
Chart 12 3: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2025
Chart 12 4: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 – 2025
Chart 12 5: EP Conventional Catheter Market by Segment, U.S., 2015 – 2025
Chart 12 6: Total EP Conventional Catheter Market, U.S., 2015 – 2025
Chart 12 7: Fixed EP Catheter Market, U.S., 2015 – 2025
Chart 12 8: Steerable EP Catheter Market, U.S., 2015 – 2025
Chart 12 9: EP Advanced Catheter Market, U.S., 2015 – 2025
Chart 12 10: ICE Diagnostic Catheter Market, U.S., 2015 – 2025
Chart 12 11: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018
Chart 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 – 2025
Chart 13 2: Cardiac Ablation Catheter Market Breakdown, U.S., 2018
Chart 13 3: Cardiac Ablation Catheter Market Breakdown, U.S., 2025
Chart 13 4: Cardiac Ablation Catheter Market, U.S., 2015 – 2025
Chart 13 5: RF Ablation Market by Segment, U.S., 2015 – 2025
Chart 13 6: Total RF Ablation Catheter Market, U.S., 2015 – 2025
Chart 13 7: Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025
Chart 13 8: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025
Chart 13 9: Cryoablation Catheter Market, U.S., 2015 – 2025
Chart 13 10: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018
Chart 14 1: ICE Generator Market, U.S., 2015 – 2025
Chart 14 2: Leading Competitors, ICE Generator Market, Europe, 2018
Chart 15 1: Cryoablation Generator Market, U.S., 2015 – 2025
Chart 16 1: External Defibrillator Market by Segment, U.S., 2015 – 2025
Chart 16 2: External Defibrillator Market Breakdown, U.S., 2018
Chart 16 3: External Defibrillator Market Breakdown, U.S., 2025
Chart 16 4: Total External Defibrillator Market, U.S., 2015 – 2025
Chart 16 5: Automated External Defibrillator Market, U.S., 2015 – 2025
Chart 16 6: Wearable Cardioverter Defibrillator Market, U.S., 2015 – 2025
Chart 16 7: Leading Competitors, External Defibrillator Market, U.S., 2018
LIST OF FIGURES
Figure 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (1 of 2)
Figure 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (2 of 2)
Figure 1 3: Companies Researched in this Report
Figure 1 4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (1 of 3)
Figure 1 7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (2 of 3)
Figure 1 8: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (3 of 3)
Figure 1 9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
Figure 1 10: Procedure Codes Investigated
Figure 1 11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (1 of 2)
Figure 1 12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Pacemaker Market Products by Company
Figure 3 2: ICD Market Products by Company
Figure 3 3: CRT Device Market Products by Company
Figure 3 4: Cardiac Leads Market Products by Company
Figure 3 5: External Defibrillator Market Products by Company
Figure 3 6: Lab Systems Market Products by Company
Figure 3 7: Diagnostic EP Catheter Market Products by Company
Figure 3 8: Cardiac Ablation Catheter Products by Company (1 of 2)
Figure 3 9: Cardiac Ablation Catheter Products by Company (2 of 2)
Figure 3 10: Class 2 Device Recall Assurity
Figure 3 11: Class 2 Device Recall Zenex
Figure 3 12: Class 2 Device Recall Accent family of pacemakers
Figure 3 13: Class 1 Device Recall Fortify, Fortify Assura
Figure 3 14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
Figure 3 15: Class 2 Device Recall Ellipse
Figure 3 16: Class 2 Device Recall Allure Quadra
Figure 3 17: Class 2 Device Recall Anthem, Allure
Figure 3 18: Class 2 Device Recall Nuance
Figure 3 19: Class 1 Device Recall Optisure HV lead
Figure 3 20: Class 3 Device Recall FIRMap 60mm Catheter
Figure 3 21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
Figure 3 22: Class 2 Device Recall SMARTABLATE RF Generator System
Figure 3 23: Class 2 Device Recall ESSENTIO Pacemaker
Figure 3 24: Class 2 Device Recall PROPONENT Pacemaker
Figure 3 25: Class 2 Device Recall ACCOLADE Pacemaker
Figure 3 26: Class 2 Device Recall PROPONENT SR Pacemaker
Figure 3 27: Class 2 Device Recall PROPONENT DR Pacemaker
Figure 3 28: Class 2 Device Recall PROPONENT EL DR Pacemaker
Figure 3 29: Class 2 Device Recall PROPONENT VDD SL Pacemaker
Figure 3 30: Class 2 Device Recall PROPONENT VDD SL Pacemaker
Figure 3 31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker
Figure 3 32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker
Figure 3 33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker
Figure 3 34: Class 2 Device Recall ACCOLADE EL DR Pacemaker
Figure 3 35: Class 2 Device Recall ACCOLADE DR Pacemaker
Figure 3 36: Class 2 Device Recall ACCOLADE SR Pacemaker
Figure 3 37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker
Figure 3 38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker
Figure 3 39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker
Figure 3 40: Class 2 Device Recall ESSENTIO DR Pacemaker
Figure 3 41: Class 2 Device Recall ESSENTIO SR Pacemaker
Figure 3 42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
Figure 3 43: Class 2 Device Recall ALTRUA 2 SR Pacemaker
Figure 3 44: Class 2 Device Recall ALTRUA 2 DR Pacemaker
Figure 3 45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
Figure 3 46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
Figure 3 47: Class 2 Device Recall RESONATE EL ICD VR
Figure 3 48: Class 2 Device Recall RESONATE EL ICD DR
Figure 3 49: Class 2 Device Recall EMBLEM SICD, Model A209
Figure 3 50: Class 2 Device Recall SQRX 1010 Pulse Generator
Figure 3 51: Class 2 Device Recall EMBLEM MRI SICD Model 219
Figure 3 52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
Figure 3 53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
Figure 3 54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
Figure 3 55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
Figure 3 56: Class 2 Device Recall VALITUDE CRTP Pacemaker
Figure 3 57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
Figure 3 58: Class 2 Device Recall VISIONIST CRTP Pacemaker
Figure 3 59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
Figure 3 60: Class 2 Device Recall RESONATE X4 CRTD
Figure 3 61: Class 2 Device Recall MOMENTUM X4 CRTD
Figure 3 62: Class 2 Device Recall VIGILANT X4 CRTD
Figure 3 63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
Figure 3 64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
Figure 3 65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
Figure 3 66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
Figure 3 67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
Figure 3 68: Class 2 Device Recall 9131 Defibrillator Electrodes
Figure 3 69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
Figure 3 70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator
Figure 3 71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 3 72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 3 73: Class 2 Device Recall Medtronic EnTrust Escudo
Figure 3 74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
Figure 3 75: Class 1 Device Recall Visia AF MRI VR SureScan ICD
Figure 3 76: Class 1 Device Recall Visia AF VR ICD
Figure 3 77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
Figure 3 78: Class 2 Device Recall Evera ICD
Figure 3 79: Class 2 Device Recall Viva ICD
Figure 3 80: Class 2 Device Recall Percepta CRTP MRI SureScan
Figure 3 81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
Figure 3 82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
Figure 3 83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
Figure 3 84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
Figure 3 85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan
Figure 3 86: Class 2 Device Recall InSync III
Figure 3 87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
Figure 3 88: Class 2 Device Recall Achieve Electrical Cable
Figure 3 89: Class 2 Device Recall Medtronic CryoConsole
Figure 3 90: Class 2 Device Recall Platinium DR 1510
Figure 3 91: Class 2 Device Recall Platinium VR 1210
Figure 3 92: Class 2 Device Recall Platinium DR DF4 1540
Figure 3 93: Class 2 Device Recall Platinium VR DF4 1240
Figure 3 94: Class 2 Device Recall PARADYM
Figure 3 95: Class 2 Device Recall OVATIO
Figure 3 96: Class 2 Device Recall INTENSIA
Figure 3 97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
Figure 3 98: Class 2 Device Recall Platinium CRTD 1741
Figure 3 99: Class 2 Device Recall Platinium CRT DF1 1711
Figure 3 100: Class 2 Device Recall PARADYM
Figure 3 101: Class 2 Device Recall OVATIO
Figure 3 102: Class 2 Device Recall INTENSIA
Figure 3 103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
Figure 3 104: Class 2 Device Recall Philips HeartStart FRx AED
Figure 3 105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED
Figure 3 106: Class 3 Device Recall XL Defibrillator
Figure 3 107: Class 2 Device Recall Philips QCPR Meter CPR feedback device
Figure 3 108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
Figure 3 109: Class 2 Device Recall Philips HeartStart
Figure 3 110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter
Figure 3 111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter
Figure 3 112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter
Figure 3 113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco Variable Diagnostic
Figure 3 114: Class 2 Device Recall Stryker Sustainability Solutions
Figure 3 115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic Electrophysiology Catheters
Figure 3 116: Class 2 Class 2 Device Recall OneStep CPR Complete
Figure 3 117: Class 2 Device Recall LifeVest Wearable Defibrillator
Figure 3 118: SJM Brady MRI Post Approval Study
Figure 3 119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
Figure 3 120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
Figure 3 121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Figure 3 122: BIO|MASTER.Edora Family Study
Figure 3 123: China Micra Transcatheter Pacing Study
Figure 3 124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
Figure 3 125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study
Figure 3 126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
Figure 3 127: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 3 128: Micra Transcatheter Pacing System Continued Access Study Protocol
Figure 3 129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
Figure 3 130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF)
Figure 3 131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
Figure 3 132: Extravascular ICD Pilot Study
Figure 3 133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies
Figure 3 134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death
Figure 3 135: BIO|MASTER.Ilivia Family/Plexa
Figure 3 136: The REACT-ICD Trial (REACT-ICD)
Figure 3 137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial
Figure 3 138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT)
Figure 3 139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure - An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment (PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial)
Figure 3 140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
Figure 3 141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure, Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study.
Figure 3 142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization Therapy Versus Rate Responsive Pacing: A Mechanistic Study
Figure 3 143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial)
Figure 3 144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE)
Figure 3 145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization Pacing with Triventricular Pacing
Figure 3 146: Responders and Quadripolar LV Lead in CRT
Figure 3 147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint ""Death or Non-planned Hospitalization for Heart Failure (HF)"" in Patients with HF and Prolonged QRS
Figure 3 148: Plexa ICD Lead Registry
Figure 3 149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector
Figure 3 150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR)
Figure 3 151: Avoid Transvenous Leads in Appropriate Subjects
Figure 3 152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy
Figure 3 153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated
Figure 3 154: Attain Stability™ Quad Clinical Study
Figure 3 155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP))
Figure 3 156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation
Figure 3 157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP)
Figure 3 158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy
Figure 3 159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study
Figure 3 160: Acute Extravascular Defibrillation Study
Figure 3 161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance
Figure 3 162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad Positioning
Figure 3 163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Figure 3 164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter
Figure 3 165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR)
Figure 3 166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia
Figure 3 167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
Figure 3 168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
Figure 3 169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development
Figure 3 170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Figure 3 171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System
Figure 3 172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute Tissue Changes During Isolation of the Pulmonary Veins
Figure 3 173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry
Figure 3 174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System
Figure 3 175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter
Figure 3 176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia
Figure 3 177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness
Figure 3 178: FIRE AND ICE II Trial Pilot
Figure 3 179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)
Figure 3 180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation
Figure 3 181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success
Figure 3 182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
Figure 3 183: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Figure 3 184: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter
Figure 3 185: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
Figure 3 186: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter
Figure 3 187: ArcticLine Feasibility Study
Figure 3 188: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
Figure 3 189: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation
Figure 3 190: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
Figure 3 191: CoolLoop Paroxysmal Atrial Fibrillation
Figure 3 192: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation
Figure 3 193: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter
Figure 3 194: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
Figure 3 195: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation
Figure 3 196: Cryterion Cardiac Cryoablation System First in Man Clinical Study
Figure 3 197: STOP Persistent AF
Figure 3 198: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure
Figure 3 199: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
Figure 3 200: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
Figure 3 201: Laser Ablation Study for trEatment of atRial Fibrillation (LASER)
Figure 3 202: A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF)
Figure 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 (US$M) (1 of 2)
Figure 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 (US$M) (2 of 2)
Figure 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 – 2025 (1 of 2)
Figure 4 4: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 – 2025 (2 of 2)
Figure 4 5: Drivers and Limiters, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018
Figure 4 6: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (1 of 2)
Figure 4 7: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (2 of 2)
Figure 4 8: SWOT Analysis, Abbott (1 of 2)
Figure 4 9: SWOT Analysis, Abbott (2 of 2)
Figure 4 10: SWOT Analysis, Biosense Webster
Figure 4 11: SWOT Analysis, Biotronik
Figure 4 12: SWOT Analysis, Boston Scientific
Figure 4 13: SWOT Analysis, Cardiac Science
Figure 4 14: SWOT Analysis, GE Healthcare
Figure 4 15: SWOT Analysis, Medtronic
Figure 4 16: SWOT Analysis, MicroPort (1 of 2)
Figure 4 17: SWOT Analysis, MicroPort (2 of 2)
Figure 4 18: SWOT Analysis, ZOLL
Figure 5 1: Procedure Codes Investigated, U.S., 2018
Figure 5 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025 (1 of 2)
Figure 5 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025 (2 of 2)
Figure 6 1: Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 6 2: Total Pacemaker Market, U.S., 2015 – 2025
Figure 6 3: Single-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 6 4: Total Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 5: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 6: Replacement Single-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 7: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 6 8: Total Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 9: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 10: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025
Figure 6 11: Leadless Pacemaker Market, U.S., 2015 – 2025
Figure 6 12: Pricing Tiers, Pacemaker Market, U.S., 2018
Figure 6 13: Drivers and Limiters, Pacemaker Market, U.S., 2018
Figure 6 14: Leading Competitors, Pacemaker Market, U.S., 2018
Figure 7 1: ICD Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 7 2: Total ICD Market, U.S., 2015 – 2025
Figure 7 3: Single-Chamber ICD Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 7 4: Total Single-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 5: Initial Placement Single-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 6: Replacement Single-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 7: Dual-Chamber ICD Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 7 8: Total Dual-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 9: Initial Placement Dual-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 10: Replacement Dual-Chamber ICD Market, U.S., 2015 – 2025
Figure 7 11: S-ICD Market, U.S., 2015 – 2025
Figure 7 12: Drivers and Limiters, ICD Market, U.S., 2018
Figure 7 13: Leading Competitors, ICD Market, U.S., 2018
Figure 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 8 2: Total CRT Market, U.S., 2015 – 2025
Figure 8 3: CRT-P Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 8 4: Total CRT-P Market, U.S., 2015 – 2025
Figure 8 5: Initial Placement CRT-P Market, U.S., 2015 – 2025
Figure 8 6: Replacement CRT-P Market, U.S., 2015 – 2025
Figure 8 7: CRT-D Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 8 8: Total CRT-D Market, U.S., 2015 – 2025
Figure 8 9: Initial Placement CRT-D Market, U.S., 2015 – 2025
Figure 8 10: Replacement CRT-D Market, U.S., 2015 – 2025
Figure 8 11: Drivers and Limiters, CRT Market, U.S., 2018
Figure 8 12: Leading Competitors, CRT Market, U.S., 2018
Figure 9 1: Cardiac Lead Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 9 2: Total Cardiac Lead Market, U.S., 2015 – 2025
Figure 9 3: Pacing Lead Market, U.S., 2015 – 2025
Figure 9 4: Defibrillation Lead Market, U.S., 2015 – 2025
Figure 9 5: LV Lead Market, U.S., 2015 – 2025
Figure 9 6: Drivers and Limiters, Cardiac Lead Market, U.S., 2018
Figure 9 7: Leading Competitors, Cardiac Lead Market, U.S., 2018
Figure 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 10 2: Resting ECG Device Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 10 3: Total Resting ECG Device Market, U.S., 2015 – 2025
Figure 10 4: Hospital-Based Resting ECG Device Market, U.S., 2015 – 2025
Figure 10 5: Office-Based Resting ECG Device Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 10 6: Total Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Figure 10 7: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Figure 10 8: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 – 2025
Figure 10 9: Stress Testing Device Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 10 10: Total Stress Testing Device Market, U.S., 2015 – 2025
Figure 10 11: Hospital-Based Stress Testing Device Market, U.S., 2015 – 2025
Figure 10 12: Office-Based Stress Testing Device Market, U.S., 2015 – 2025
Figure 10 13: Holter Monitoring Recorder Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 10 14: Total Holter Monitoring Recorder Market, U.S., 2015 – 2025
Figure 10 15: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025
Figure 10 16: Office-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025
Figure 10 17: IDTF Holter Monitoring Recorder Market, U.S., 2015 – 2025
Figure 10 18: Drivers and Limiters, Electrocardiography Monitoring Market, U.S., 2018
Figure 10 19: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018
Figure 11 1: Lab Systems Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 11 2: 3D Mapping Market, U.S., 2015 – 2025
Figure 11 3: EP Recording Market, U.S., 2015 – 2025
Figure 11 4: RF Ablation Generator Market, U.S., 2015 – 2025
Figure 11 5: Remote Steering System Market, U.S., 2015 – 2025
Figure 11 6: Drivers and Limiters, Lab Systems Market, U.S., 2018
Figure 11 7: Leading Competitors, Lab Systems Market, U.S., 2018 (1 of 2)
Figure 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 12 2: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 – 2025
Figure 12 3: EP Conventional Catheter Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 12 4: Total EP Conventional Catheter Market, U.S., 2015 – 2025
Figure 12 5: Fixed EP Catheter Market, U.S., 2015 – 2025
Figure 12 6: Steerable EP Catheter Market, U.S., 2015 – 2025
Figure 12 7: EP Advanced Catheter Market, U.S., 2015 – 2025
Figure 12 8: ICE Diagnostic Catheter Market, U.S., 2015 – 2025
Figure 12 9: Drivers and Limiters, Diagnostic Electrophysiology Catheters Market, U.S., 2018
Figure 12 10: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018
Figure 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 13 2: Cardiac Ablation Catheter Market, U.S., 2015 – 2025
Figure 13 3: RF Ablation Catheter Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 13 4: Total RF Ablation Catheter Market, U.S., 2015 – 2025
Figure 13 5: Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025
Figure 13 6: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025
Figure 13 7: Cryoablation Catheter Market, U.S., 2015 – 2025
Figure 13 8: Drivers and Limiters, Cardiac Ablation Catheter Market, U.S., 2018
Figure 13 9: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018
Figure 14 1: ICE Generator Market, U.S., 2015 – 2025
Figure 14 2: Drivers and Limiters, ICE Generator Market, U.S., 2018
Figure 14 3: Leading Competitors, ICE Generator Market, U.S., 2018
Figure 15 1: Cryoablation Generator Market, U.S., 2015 – 2025
Figure 15 2: Drivers and Limiters, Cryoablation Generator Market, U.S., 2018
Figure 16 1: External Defibrillator Market by Segment, U.S., 2015 – 2025 (US$M)
Figure 16 2: Total External Defibrillator Market, U.S., 2015 – 2025
Figure 16 3: Automated External Defibrillator Market, U.S., 2015 – 2025
Figure 16 4: Wearable Cardioverter Defibrillator Market, U.S., 2015 – 2025
Figure 16 5: Drivers and Limiters, External Defibrillator Market, U.S., 2018
Figure 16 6: Leading Competitors, External Defibrillator Market, U.S., 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook